**Acknowledgements**

We would like to thank the Hessen State Ministry of Higher Education, Research and the Arts for the financial support within the Hessen initiative for scientific and economic excellence (LOEWE-Program, LOEWE Center DRUID (Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases)). We also received financial support from the Strategic Research Fund of the THM (University of Applied Sciences Mittelhessen). The authors acknowledge Dr. Richard M Twyman for revising the paper.

**219**

**Author details**

, Florian Petry1

Applied Ecology (IME), Giessen, Germany

provided the original work is properly cited.

\*Address all correspondence to: denise.salzig@lse.thm.de

, Jan Zitzmann1

1 Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Giessen, Germany

2 Faculty of Biology and Chemistry, Justus-Liebig-University Giessen, Giessen,

3 Project Group Bioresources, Fraunhofer Institute for Molecular Biology and

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

, Peter Czermak1,2,3 and Denise Salzig1

\*

Jan Barekzai1

Germany

*Bioprocess Development for Human Mesenchymal Stem Cell Therapy Products*

*DOI: http://dx.doi.org/10.5772/intechopen.90029*
